A recent study found that older adults with diabetes who use a GLP-1 drug have double the risk of developing wet age-related ...

If you’re considering using medication to reach a healthy body weight, your first question might be: Are weight loss drugs covered by insurance? The short answer: Sometimes, but not always.

A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

This episode of Chromatography Life takes a closer look at synthetic peptide drugs - one of the most compelling frontiers in biopharmaceutical analysis.

Analysts at William Blair believe dapiglutide’s 11.6% weight reduction could still be better, given that Zealand’s study ...

With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...

GLP-1 medications such as Wegovy, Mounjaro and Ozempic helped drive a 9% year-over-year increase in U.S. prescription dispensing revenue, which reached $683 billion in 2024.  A separate report found ...

Among patients with moderate peripheral artery disease, GLP-1 use was associated with reduced risk for cardiovascular and ...

In a move that could reshape how doctors approach both weight and heart health, the American College of Cardiology (ACC) ...